Nusret Köse

Prof. Dr. Nusret Köse

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
RCRobert M. Campbell
Robert M. Campbell
MSMelvin D. Smith
Melvin D. Smith
TMThomas C. Mayes
Thomas C. Mayes
JMJohn A. Mangos
John A. Mangos
DWDonna B. Willey-Courand
Donna B. Willey-Courand
JSJennifer L. Surber
Jennifer L. Surber
Thoracic insufficiency syndrome is the inability of the thorax to support normal respiration or lung growth.The rare condition of fused ribs and congenital scoliosis may result in a three-dimensional thoracic deformity with adverse effects on thoracic growth and function with development of thoracic

1 August 2004 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
RCRobert M. Campbell
Robert M. Campbell
MSMelvin D. Smith
Melvin D. Smith
TMThomas C. Mayes
Thomas C. Mayes
JMJohn A. Mangos
John A. Mangos
DWDonna B. Willey-Courand
Donna B. Willey-Courand
JSJennifer L. Surber
Jennifer L. Surber
Background: Thoracic insufficiency syndrome is the inability of the thorax to support normal respiration or lung growth and is seen in patients who have severe congenital scoliosis with fused ribs. Traditional spinal surgery does not directly address this syndrome.

1 September 1996 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
IGIzge Günal
Izge Günal
NKNusret Köse
Nusret Köse
OEOral Erdogan
Oral Erdogan
EGErol Göktürk
Erol Göktürk
SSSinan Seber
Sinan Seber
Ere significantly smaller than those on the left. We concluded that the contralateral, normal side may not always be a reliable control in the evaluation of restriction of motion of a joint....

1 August 2013 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
NKNusret Köse
Nusret Köse
AOAli Otuzbir
Ali Otuzbir
CPCeren Pekşen
Ceren Pekşen
AKAbdurrahman Kiremitçi
Abdurrahman Kiremitçi
ADAydın Doğan
Aydın Doğan
Ontaining calcium phosphate-based ceramic nanopowder coating to provide antibacterial activity for orthopaedic implants. Questions/purposes We asked whether titanium prostheses coated with this nanopowder would show resistance to bacterial colonization as compared with uncoated prostheses. Methods We inserted titanium implants (uncoated [n = 9], hydroxyapatite-coated [n = 9], silver-coated [n = 9]) simulating knee prostheses into 27 rabbits’ knees. Before implantation, 5 × 102 colony-forming units of Staphylococcus aureus were inoculated into the femoral canal. Radiology, microbiology, and histology findings were quantified at Week 6 to define the infection, microbiologically by increased rate of implant colonization/positive cultures, histologically by leukocyte infiltration, necrosis, foreign-body granuloma, and devitalized bone, and radiographically by periosteal reaction, osteolysis, or sequestrum formation. Results Swab samples taken from medullary canals and implants revealed a lower proportion of positive culture in silver-coated implants (one of nine) than in uncoated (eight of nine) or hydroxyapatite-coated (five of nine) implants. Silver-coated implants also had a lower rate of colonization. No cellular inflammation or foreign-body granuloma was observed around the silver-coated prostheses. Conclusions Silver ion-doped ceramic nanopowder coating of titanium implants led to an increase in resistance to bacterial colonization compared to uncoated implants. Clinical Relevance Silver-coated orthopaedic implants may be useful for resistance to local infection but will require in vivo confirmation....

1 May 2016 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
PDF file
HÖHakan Ömeroğlu
Hakan Ömeroğlu
NKNusret Köse
Nusret Köse
AAAnil Akceylan
Anil Akceylan
Treatment of developmental dysplasia of the hip (DDH) using the Pavlik harness has been a widely used method in patients between 0 and 6 months of age for many years. However, the factors influencing the success rate of this treatment modality have still not exactly been determined as a result of the limited number of clinical studies with higher level of evidence. We, therefore, asked whether (1) patient-related variables such as age, gender, and laterality; coexisting risk factors including family history, breech presentation, intrauterine packing, first-born girl, oligohydroamnios, and swaddling; and (2) the severity of hip dysplasia, defined by ultrasonography, are associated with differences in the success rate of Pavlik harness treatment in infants with DDH. Between 2012 and 2014, we treated 153 children (≤ 6 months of age) with DDH using the Pavlik harness. Hip dysplasia apart from coexisting neuromuscular disorders, congenital abnormalities, or syndromes was our inclusion criteria. Of patients thus treated, 130 (85%) were available for the evaluation of patient- and hip-related variables against the success of Pavlik harness treatment. Mean age of these patients on day of diagnosis and initiation of treatment was 108 days. The diagnostic and followup examinations of the hips were made by ultrasonography using Graf’s method. Pavlik harness treatment was initiated in Graf Type IIa- and worse hips and treatment was considered “successful” when a Graf Type I hip was achieved. Pavlik harness treatment was successful in 92 (71%) patients (130 of 181 hips [72%]). Age was the only patient-related variable influencing the success rate of the treatment; the mean age of children in whom Pavlik harness treatment succeeded (97 ± 38 days; 95% confidence interval [CI], 90–112) was lower than the age of those who failed (135 ± 37 days; 95% CI, 123–147; p < 0.001). The highest success rate was obtained in children younger than age 3 months (37 of 40 [93%]) and the lowest one older than age 5 months (nine of 24 [37%]) (p < 0.001). The threshold age value related to an increased risk of failure was found to be 4 months and older, which had a sensitivity of 66% and a specificity of 77% (p < 0.001). A higher initial α angle was observed in the hips in which the treatment succeeded (53° ± 6°; 95% CI, 51°–53°) than in those that failed (47° ± 7°; 95% CI, 45°–50°; p < 0.001). The threshold α angle value related to an increased risk of treatment failure was 46° and less, which had a sensitivity of 47% and a specificity of 86% (p < 0.001). Dislocated hips (Graf Type III and IV hips) had the lowest rate of treatment success (five of 19 [26%] and two of four [50%], respectively), whereas Graf Type IIa- hips had the highest (27 of 29 [93%]) (p < 0.001). We conclude that Pavlik harness treatment is less effective in children at and over the age of 4 months at the time the harness is first applied as well as in hips with complete dislocations and hips with severely deficient acetabular bony roofs. In such older patients and worse hip types, the use of initial Pavlik harness treatment needs to be revisited. Future studies, comparing the outcomes of the Pavlik harness treatment and other types of interventions in such patients and hip types, are needed. Level III, therapeutic study.

25 April 2000 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
SSSinan Seber
Sinan Seber
BHBülent Hazer
Bülent Hazer
NKNusret Köse
Nusret Köse
EGErol Göktürk
Erol Göktürk
IGIzge Günal
Izge Günal
ATAkın Turgut
Akın Turgut